These findings are consistent with findings in other neurodegenerative diseases, i.e. α-synucleinopathies and tauopathies, where an increase in CSF NfL concentrations is present before the onset of neurological signs detetected14. This evidence concerns the gene NEFL and neurodegenerative disease.